Glucose intolerance in women with preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 77, Issue 1, 1998, Pages 22-27

  Lorentzen, Bjørg ^a   Birkeland, Kåre I ^a   Endresen, Marit J ^a   Henriksen, Tore ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endothelial cells; Free fatty acids; Insulin resistance; Preeclampsia

Indexed keywords

C PEPTIDE; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; PROTEIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031975614     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016349808565805     Document Type: Article

References (38)

1. Redman CWG. Current topic: pre-eclampsia and placenta. Placenta 1991; 12: 301-8.
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.
3. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440-7.
4. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertension in Pregnancy 1994; 13(1): 103-9.
5. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 1995; 102: 530-7.
6. Kokia E, Barkai G, Reichman B, Segal P, Goldman B, Mashiach S. Maternal serum profile in pregnancies complicated by hypertensive disorders. J Prenatal Med 1990; 18: 473-8.
7. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991; 63: 363-72.
8. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
9. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-40.
10. Reaven GM. Role of insulin resistance in human diseases. Diabetes 1988; 37:1595-607.
11. Sowers JR, Standly PR, Ram JL, Jacober S, Simpson L, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993; 6: 260S-270S.
12. Donahue RP, Orchard TJ, Becher DJ, Kuller LH, Drash AL. Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County study. Am J Epidemiol 1987; 125: 650-7.
13. Modan M, Orr J, Karasik A, Drory Y, Fuchs Z, Lusky A et al. Hyperinsulinemia, sex and atherosclerotic cardiovascular disease. Circulation 1991; 84: 1165-75.
14. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81: 2908-11.
15. Solomon CG, Graves SW, Greene MF, Seely EW. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994; 23(1): 717-21.
16. Jónsdóttir LS, Arngrímsson R, Geirsson RT, Sigvaldason H, Sigfússon N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-6.
17. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-9.
18. Øian P, Kjeldsen SE, Eide I, Maltau JM. Increased arterial catecholamines in pre-eclampsia. Acta Obstet Gynecol Scand 1986; 65(6): 613-17.
19. Long PA, Abell DA, Beischer NA. Importance of abnormal glucose tolerance (hypoglycæmia and hyperglycæmia) in the aetiology of pre-eclampsia. Lancet 1977; April 30: 923.
20. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
21. DeFronzo R, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-68.
22. Kumar S, Durrington PN, Bhatnagar D, Laing I. Suppression of non-esterified fatty acids to treat type A insulin resistance syndrome. Lancet 1994; 343: 1073-4.
23. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 1985; 26: 1015-35.
24. Pelikánova T, Kohout M, Válek J, Kazdová L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989; 38(2): 188-92.
25. Tong P, Thomas T, Berrish T, Humphriss D, Barriocanal L, Stewart M et al. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet 1995; 345: 357-8.
26. Paolisso G, Gambardella A, Balbi V, Varricchio M, D'Onofrio F. Opposite effects of short-and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetes 1995; 44(1): 43A.
27. Beck-Nielsen H, Groop JC. Metabolic and genetic characterization of prediabetic states. J Clin Invest 1994; 94: 1714-21.
28. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesteryl esters. Diabetes 1994; 43: 1353-7.
29. Wang Y, Kay HH, Killam AP. Decreased levels of polyunsaturated fatty acids in preeclampsia. Am J Obstet Gynecol 1991; 169: 1462-6.
30. Wang Y, Walsh SW, Guo J, Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991; 165: 1695-1700.
31. Branch DW, Mitchell MD, Miller E, Palanski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidised lowdensity lipoprotein. Lancet 1994; 343: 645-6.
32. Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine. Second edition. Oxford, Clarendon Press, 1989.
33. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chrisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238-44.
34. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85: 353-6.
35. Endresen MJ, Tøsti E, Heimli H, Lorentzen B, Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and to inhibit platelet aggregation. Scand J Clin Lab Invest 1994; 54: 549-57.
36. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-7.
37. Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand 1992; 72: 269-72.
38. Björntorp B. Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Curr Opin Lipidol 1994; 5: 166-74.